
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.600 | 2.600 | 0.000 |
Shares | 97.400 | 97.400 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.213 | 17.880 |
Price to Book | 5.938 | 3.321 |
Price to Sales | 3.039 | 2.209 |
Price to Cash Flow | 16.709 | 13.754 |
Dividend Yield | 2.662 | 2.916 |
5 Years Earnings Growth | 7.181 | 10.445 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 35.700 | 30.677 |
Industrials | 19.260 | 15.686 |
Consumer Defensive | 14.160 | 12.822 |
Financial Services | 12.850 | 21.764 |
Basic Materials | 10.060 | 8.216 |
Consumer Cyclical | 5.330 | 5.427 |
Technology | 2.640 | 3.446 |
Number of long holdings: 23
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 13.79 | 79.29 | +0.38% | |
Roche Holding Participation | CH0012032048 | 12.83 | 261.60 | -0.19% | |
Novartis | CH0012005267 | 10.67 | 96.18 | +0.17% | |
Zurich Insurance Group | CH0011075394 | 8.01 | 555.20 | +0.29% | |
ABB | CH0012221716 | 6.58 | 47.79 | +4.28% | |
Lonza Group | CH0013841017 | 6.36 | 566.60 | +0.60% | |
Givaudan | CH0010645932 | 5.60 | 3,907.00 | +0.72% | |
Partners Group | CH0024608827 | 4.51 | 1,030.00 | +2.03% | |
Sika | CH0418792922 | 4.20 | 219.90 | +2.04% | |
Richemont | CH0210483332 | 3.85 | 149.55 | +2.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BCV PENSION 25 AP | 905.42M | 0.89 | 2.58 | 1.90 | ||
BCV PENSION 40 AP | 655.76M | 1.19 | 3.19 | 3.18 | ||
Synchrony All Caps CH I | 575.4M | 7.18 | 1.71 | 7.18 | ||
Synchrony Small Mid Caps CH I | 189.66M | 5.07 | 0.02 | 7.17 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review